Topics / Peptides & Compounds
Peptides & Compounds
The research peptides: mechanism, evidence, safety, stability, and sourcing talk within the rules.
4 guidesone evidence laddernot yet clinically reviewed
Peptides
4- TeduglutideGLP-2 receptor agonistA GLP-2 analog approved for short bowel syndrome. A useful example of a peptide with a narrow, well-defined indication and a correspondingly narrow evidence base.Established
- Afamelanotide (MT-1)Selective melanocortin-1 receptor (MC1R) agonistThe melanocortin agonist that completed development. Approved for a rare light-sensitivity disorder, and the direct counterexample to melanotan II.Established
- LL-37Human cathelicidin antimicrobial peptideThe only human cathelicidin, with a very large basic-science literature and a small clinical one. Its dual role, antimicrobial and immunomodulatory, is also why its effects are hard to predict.Early clinical
- Vasoactive Intestinal PeptideTwenty-eight-residue neuropeptideA well characterized endogenous neuropeptide with an enormous basic literature, and a clinical history dominated by one contested and heavily publicized COVID-19 program.Contested
Community
Talk it through in the Peptides & Compounds room.
The guides say what the studies found. The room is where people compare what happened to them, and every post is labeled as anecdote or cited research so the two are never confused. Reading and posting take a free account.
For Research & Educational Discussion Only. Not Medical Advice
Everything on Baseline is community discussion and educational material. It is not medical care, diagnosis, treatment, or prescribing, and no one here is acting as your clinician. Talk to a licensed healthcare professional before making any decision about your health.